SUTRO BIOPHARMA, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $91.6M | $223.1M | $125.3M |
| FY2019 | $58.6M | $156.4M | $5.0M |
| FY2020 | $62.1M | $394.1M | $206.2M |
| FY2021 | $88.8M | $341.4M | $30.4M |
| FY2022 | $189.9M | $406.9M | $47.3M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $91.6M | $223.1M | $125.3M |
| FY2019 | $58.6M | $156.4M | $5.0M |
| FY2020 | $62.1M | $394.1M | $206.2M |
| FY2021 | $88.8M | $341.4M | $30.4M |
| FY2022 | $189.9M | $406.9M | $47.3M |